SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-050368
Filing Date
2021-10-07
Accepted
2021-10-07 07:10:32
Documents
14
Period of Report
2021-10-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlry-8k_20211007.htm   iXBRL 8-K 42406
2 EX-99.1 tlry-ex991_8.htm EX-99.1 992983
3 GRAPHIC gpzphyaodzdu000001.jpg GRAPHIC 48950
  Complete submission text file 0001564590-21-050368.txt   1268908

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tlry-20211007.xsd EX-101.SCH 5677
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20211007_lab.xml EX-101.LAB 19330
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20211007_pre.xml EX-101.PRE 11480
7 EXTRACTED XBRL INSTANCE DOCUMENT tlry-8k_20211007_htm.xml XML 3547
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 211311045
SIC: 2833 Medicinal Chemicals & Botanical Products